The trials and tribulations of the University Group Diabetes Program 1: the trial and the controversies

被引：3

作者：

Meinert, Curtis ^{[1
]}

机构：

[1] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD 21205 USA

来源：

关键词：

VASCULAR COMPLICATIONS; HYPOGLYCEMIC AGENTS; NONFATAL EVENTS;

D O I：

10.1177/0141076819884869

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

[No abstract available]

引用

页码：476 / 482

页数：7

共 16 条

[1]

[Anonymous], 1975, JAMA, V231, P583

[2]

[Anonymous], 1982, Diabetes, V31 Suppl 5, P1

[3]

[Anonymous], JAMA

[4]

[Anonymous], 1970, Diabetes, V19, P747

[5]

[Anonymous], 1975, DIABETES, V24, P65

[6]

[Anonymous], DIABETES S2

Blackburn, Henry ;

Jacobs, David R., Jr. .

[8] SETTLING UGDP CONTROVERSY [J].

BRADLEY, RF ;

DOLGER, H ;

FORSHAM, PH ;

SELTZER, H .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1975, 232 (08) :813-817

[9]

Greene Jeremy., 2009, PRESCRIBING NUMBERS

[10]

KNATTERUD GL, 1978, JAMA-J AM MED ASSOC, V240, P37, DOI 10.1001/jama.240.1.37